HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway

Altucci, 2005, Acute myeloid leukemia: Therapeutic impact of epigenetic drugs, Int. J. Biochem. Cell. Biol., 37, 1752, 10.1016/j.biocel.2005.04.019 Backs, 2006, CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy, J. Clin. Invest., 10.1172/JCI27438 Gurvich, 2004, Histone deacetylase is a target of valproic acid-mediated cellular differentiation, Cancer Res., 64, 1079, 10.1158/0008-5472.CAN-03-0799 Inoue, 2006, Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis, Cancer Res., 66, 6785, 10.1158/0008-5472.CAN-05-4563 Insinga, 2005, Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway, Nat. Med., 11, 71, 10.1038/nm1160 Mai, 2005, Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides, J. Med. Chem., 48, 3344, 10.1021/jm049002a Marks, 2004, Histone deacetylase inhibitors: Development as cancer therapy, Novartis Found Symp., 259, 269, 10.1002/0470862637.ch20 McKinsey, 2006, Class II histone deacetylases confer signal responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK, Mol. Biol. Cell., 17, 438, 10.1091/mbc.E05-07-0612 Minucci, 2006, Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer, Nat. Rev. Cancer, 6, 38, 10.1038/nrc1779 Nebbioso, 2005, Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells, Nat. Med., 11, 77, 10.1038/nm1161 Vega, 2004, Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis, Cell, 119, 555, 10.1016/j.cell.2004.10.024 Verdin, 2003, Class II histone deacetylases: Versatile regulators, Trends Genet., 19, 286, 10.1016/S0168-9525(03)00073-8 Yang, 2005, Class II histone deacetylases: From sequence to function, regulation, and clinical implication, Mol. Cell. Biol., 25, 2873, 10.1128/MCB.25.8.2873-2884.2005